ASX
Telix Pharmaceuticals Limited
TLX:ASX•Healthcare
Sensitive ASX Announcement
Phase III Prostate Cancer Therapy Clinical Trial Commences
Published: 10/05/21, 08:21am (AEST)•2 pages